Survival rates for cancer are the highest they’ve ever been — but these 3 will cause the most deaths in 2026

Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...
The American Journal of Managed Care

Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma

Socioeconomic and demographic factors impact surgical outcomes in upper extremity soft tissue sarcomas, affecting amputation ...

Cancer survival rates soar nationwide, but L.A. doctors warn cultural and educational barriers leave some behind

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer can expect to live at least five years. The increase from the mid-1970s, ...

Cancer survival rates reach record high, but deadliest types still put Americans at risk

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...
The American Journal of Managed Care

Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma

Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...
MarketWatch

Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and ...

The MarketWatch News Department was not involved in the creation of this content. -- Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically ...